Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 4 | 5 | 4 |
| (72.61%) | (89.48%) | (81.58%) | (67.44%) | ||
| (12.53%) | (15.31%) | (16.47%) | (12.75%) | ||
ROIC |
(15.23%) | (16.20%) | (16.63%) | (17.87%) | |
Return on Tangible Assets |
(22.98%) | (27.72%) | (36.74%) | (25.74%) | |
Average Days of Receivables |
93.66 | 89.31 | 82.57 | 91.99 | |
Free Cash Flow per Share |
(1.43) | (1.41) | (1.23) | (1.52) | |
Free Cash Flow |
(249.44) | (245.35) | (219.70) | (272.97) | |
Capital Expenditures |
(28.89) | (27.26) | (33.96) | (35.54) | |
| Other line items | |||||
Cash ROIC |
(9.93%) | (9.87%) | (9.60%) | (10.41%) | |
Accounts Receivable Turnover |
5.15 | 5.46 | 4.78 | 4.57 | |
Accounts Payable Turnover |
7.79 | 6.98 | 7.70 | 6.74 | |
Inventory Turnover |
9.29 | 10.52 | 9.76 | 10.20 | |
Average Days of Payables |
51.39 | 63.15 | 29.98 | 52.23 | |
Days of Inventory on Hand |
47.44 | 39.84 | 37.88 | 37.87 | |
Tax Rate |
(0.19) | (0.18) | (0.02) | (0.02) | |
Research and Development Expense of Revenue |
26.23% | 25.09% | 25.21% | 25.45% | |
Selling, General and Administrative Expense of Revenue |
57.41% | 57.54% | 57.89% | 58.30% | |
Share Based Compensation of Revenue |
9.43% | 9.81% | 11.32% | 13.00% | |
Interest Coverage |
(3.54) | (3.60) | (4.04) | (5.12) | |
Operating CF/Net income |
1.08 | 0.89 | 0.61 | 0.93 | |
Depreciation/Fixed assets |
0.99 | 1.20 | 1.28 | 1.26 | |
Capex/Depreciation |
(0.32) | (0.26) | (0.30) | (0.32) | |
Revenue per Share |
6.32 | 7.30 | 7.63 | 7.96 | |
Operating CF per Share |
(1.26) | (1.25) | (1.04) | (1.32) | |
Capex per Share |
(0.17) | (0.16) | (0.19) | (0.20) | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.02 |
Columns are period end dates